Literature DB >> 12447695

Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities.

Elaine Stead1, Josephine White, Renate Faast, Simon Conn, Sherilyn Goldstone, Joy Rathjen, Urvashi Dhingra, Peter Rathjen, Duncan Walker, Stephen Dalton.   

Abstract

Pluripotent cells of embryonic origin proliferate at unusually rapid rates and have a characteristic cell cycle structure with truncated gap phases. To define the molecular basis for this we have characterized the cell cycle control of murine embryonic stem cells and early primitive ectoderm-like cells. These cells display precocious Cdk2, cyclin A and cyclin E kinase activities that are conspicuously cell cycle independent. Suppression of Cdk2 activity significantly decreased cycling times of pluripotent cells, indicating it to be rate-limiting for rapid cell division, although this had no impact on cell cycle structure and the establishment of extended gap phases. Cdc2-cyclin B was the only Cdk activity that was identified to be cell cycle regulated in pluripotent cells. Cell cycle regulation of cyclin B levels and Y(15) regulation of Cdc2 contribute to the temporal changes in Cdc2-cyclin B activity. E2F target genes are constitutively active throughout the cell cycle, reflecting the low activity of pocket proteins such as p107 and pRb and constitutive activity of pRb-kinases. These results show that rapid cell division cycles in primitive cells of embryonic origin are driven by extreme levels of Cdk activity that lack normal cell cycle periodicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447695     DOI: 10.1038/sj.onc.1206015

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  157 in total

1.  Microfluidics-integrated time-lapse imaging for analysis of cellular dynamics.

Authors:  Dirk R Albrecht; Gregory H Underhill; Joshua Resnikoff; Avital Mendelson; Sangeeta N Bhatia; Jagesh V Shah
Journal:  Integr Biol (Camb)       Date:  2010-03-19       Impact factor: 2.192

Review 2.  In search of "stemness".

Authors:  Jingli Cai; Mark L Weiss; Mahendra S Rao
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

3.  Signalling in stem cells: meeting on signal transduction determining the fate of stem cells.

Authors:  Lynn E Heasley; Bryon E Petersen
Journal:  EMBO Rep       Date:  2004-02-20       Impact factor: 8.807

4.  Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation.

Authors:  Yiling Hong; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

5.  Induced pluripotency leapfrogs ahead.

Authors:  Michael A Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

6.  Effects of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers on the proliferation and cell cycle progression of embryonic stem cells.

Authors:  Yuen-Ting Lau; Chun-Kit Wong; Jialie Luo; Lok-Hang Leung; Pui-Fong Tsang; Zhao-Xiang Bian; Suk-Ying Tsang
Journal:  Pflugers Arch       Date:  2010-11-26       Impact factor: 3.657

Review 7.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 8.  MicroRNAs in embryonic stem cell function and fate.

Authors:  Gustavo Tiscornia; Juan Carlos Izpisúa Belmonte
Journal:  Genes Dev       Date:  2010-12-15       Impact factor: 11.361

9.  Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells.

Authors:  Tiziana Parisi; Andreas R Beck; Nathalie Rougier; Tom McNeil; Linda Lucian; Zena Werb; Bruno Amati
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  RNA interference and retinoblastoma-related genes are required for repression of endogenous siRNA targets in Caenorhabditis elegans.

Authors:  Alla Grishok; Sebastian Hoersch; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.